Petitioner Denied A Second Bite At The Apple

Feb 9, 2015

Reading Time : 2 min

Standard Innovation filed a first petition for inter partes review of U.S. Patent No. 7,749,178 (the 178 patent) which the Board instituted on May 6, 2014 (IPR2014­00148, the 148 IPR). On June 5, 2014, Standard Innovation filed a second petition for inter partes review of the same patent (second petition), concurrent with a motion to join the second petition with the 148 IPR. This second petition was filed more than one year after petitioner was served with a complaint alleging infringement of the patent­at­issue. In such circumstances, inter partes review cannot be instituted unless it is joined with an earlier instituted proceeding pursuant to 35 U.S.C. § 315(c). Here, the board highlighted that “the decision to grant joinder is discretionary,” and in denying joinder, analyzed “the content of the petition, the impact on schedule [sic] including how petitioner proposes to deal with that impact, and other factors.” The board noted that the second petition sought review of five claims of the ’178 patent that were already denied institution in the 148 IPR, referring to it as a “second bite at the apple.” Indeed, the board stated that “[n]either the petition nor the motion for joinder presents cogent argument or evidence to explain why the grounds of unpatentability asserted in the petition could not have been asserted in the 148 IPR” and that “joinder would significantly expand the 148 IPR” (e.g., due to an increase in the number of claims, asserted grounds, and references to be considered). Thus, petitioner had not demonstrated why such an increased burden was warranted.

The board additionally mentioned a joinder issue that will likely arise again in future proceedings. Specifically, the board recognized that a “difference in opinion currently exists as to whether the board has discretion under 35 U.S.C. § 315(c) to allow joinder of a person to an ongoing inter partes review when, as here, that person is already a party to an ongoing inter partes review” (i.e., whether two petitions involving the same parties may be joined as compared to petitions involving different parties, but the same patent). Cf. Target Corp. v. Destination Maternity Corp., Case IPR2014­00508 (PTAB Sept. 25, 2014) (Paper 18); Ariosa Diagnostics v. Isis Innovation Ltd., Case IPR2012­00022 (PTAB Sept. 2, 2014) (Paper 166). The board in Standard Innovation declined to take a position on the issue, stating that “[e]ven if 35 U.S.C. § 315(c) does not permit joinder of a person to an ongoing inter partes review when that person is already a party to the ongoing inter partes review, the outcome in this case would be the same.” Given that multiple petitions are increasingly filed against the same patent, this issue is likely to arise again.

Standard Innovation Corp. v. Lelo, Inc., No. IPR2014­00907 (PTAB Dec. 1, 2014) [Kauffman, Bonilla, and Crumbley].

Share This Insight

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.